Study Inclusion Number of patients Type of metastasis Total dose per fraction Toxicity Median follow-up (months) Local control rate Survival Herfarth et al. (2001) [38] 1–3 lesions 37 Not reported…

T1 ≤ 2 cm N1 Perirectal node(s) M0 No distant metastasis T2 2–5 cm N2 Unilateral internal iliac and/or inguinal node(s) M1 Distant metastasis T3 > 5 cm N3 Perirectal…

(1) Harvard Radiation Oncology Program, Boston, MA, USA (2) Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA, USA (3) Massachusetts General Hospital, Boston, MA, USA     Sophia C. Kamran…

   Isolated locoregional failure rate (%) Initial distant failure rate (%) Extrahepatic/hilar cholangiocarcinoma Surgery alone 4–34 24–40 +adjuvant chemoradiotherapy (SWOG 0809) 8 29 Gallbladder cancer Surgery alonea 3–33 15–51 +adjuvant…

  1 point 2 points 3 points Total bilirubin (mg/dl)a <3.4 3.4–5.0 >5.0 INR <1.7 1.7–2.3 >2.3 Albumin (g/dl) >3.5 2.8–3.5 <2.8 Ascites None Mild Moderate–severe Hepatic encephalopathy None Medically…

Short-term infusional fluorouracil and leucovorin for gastrointestinal cancer (modified de Gramont schedule) [2] Each cycle is 14 days Drug Dose/route Administration  Leucovorin 400 mg/m2 IV Day 1 given over 2…

© Springer International Publishing AG 2017Theodore Hong and Prajnan Das (eds.)Radiation Therapy for Gastrointestinal Cancers10.1007/978-3-319-43115-4_5 5. Gastric Cancer: Background and Clinical Evidence Christopher L. Hallemeier1 and Michael G. Haddock1   (1) Mayo Clinic, Rochester, MN 55905, USA     Michael G. Haddock Email:…

Fig. 3.1 American Joint Committee on Cancer 2010 esophageal cancer staging system     3.5 Prognostic Factors (a) According to SEER Data, the 5-year survival of patients with esophageal cancer…